Dr. Skipper is a Fellow of the American Society of Addiction Medicine and a certified medical review officer. He previously served as medical director for the Alabama Physician Health Program and was on the council that created and oversaw the Oregon Health Professionals Program. Dr. Skipper was the primary innovator of ethyl glucuronide (EtG) testing and is an expert in alcohol biomarkers and drug testing. He was a principal investigator of the National Physician Health Program Blueprint Study, funded by a Robert Wood Johnson Foundation grant, and is the author of many articles regarding drug testing, physician health, and contingency monitoring. Dr. Skipper was formerly medical director of Springbrook Hazelden, and he was a chief advisor to the development of the professional’s program at Promises, Betty Ford Center and Bradford Health Services.